|
| | Number of genes | P values |
|
| Kegg pathways | | |
| Cytokine-cytokine receptor interaction | 10 | |
| Natural killer cell mediated cytotoxicity | 8 | |
| Hematopoietic cell lineage | 7 | |
| Antigen processing and presentation | 6 | |
| Primary immunodeficiency | 5 | |
| Ubiquitin mediated proteolysis | 5 | |
| Jak-STAT signaling pathway | 5 | |
| Graft-versus-host disease | 4 | |
| Acute myeloid leukemia | 4 | |
| Toll-like receptor signaling pathway | 4 | |
| Biocarta pathways | | |
| NO2-dependent IL 12 Pathway in NK cells | 5 | |
| Ras-independent pathway in NK cell mediated cytotoxicity | 5 | |
| IL12 and Stat4 dependent signaling pathway in Th1 development | 4 | |
| Stathmin and breast cancer resistance to antimicrotubule agents | 3 | |
| T cytotoxic cell surface molecules | 3 | |
| T helper cell surface molecules | 3 | |
| Lck and Fyn tyrosine kinases in initiation of TCR activation | 3 | |
| CTL mediated immune response against target cells | 3 | |
| IL 17 signaling pathway | 3 | |
| T cell receptor and CD3 complex | 2 | |
| Genmapp pathways | | |
| Hs_1-Tissue-Blood_and_Lymph | 9 | |
| Cell surface receptor linked signal transduction | 8 | |
| Cellular_process-Hs_T-Cell-Receptor_NetPath_11 | 8 | |
| Humoral immune response | 7 | |
| Inflammatory response | 7 | |
| Transmembrane receptor activity | 6 | |
| Humoral defense mechanism (sensu Vertebrata) | 6 | |
| Isomerase activity | 6 | |
| Lipid metabolism | 6 | |
| Hs_TNF-alpha-NF-kB_NetPath_9 | 6 | |
|
